miR-494 靶向 TLR-4 通路在骨质疏松发病中的作用及机制

doi:10. 3969 / j. issn. 1006-6179. 2023. 06. 004

实验动物科学 ›› 2023, Vol. 40 ›› Issue (6): 19-25.DOI: 10. 3969 / j. issn. 1006-6179. 2023. 06. 004

miR-494 靶向 TLR-4 通路在骨质疏松发病中的作用及机制

(武汉市第四医院骨科,武汉 430060)

收稿日期:2022-03-21 出版日期:2023-12-28 发布日期:2024-01-08
通讯作者: 程煜方( 1970—) ,男, 本科, 副主任医师, 研究方向:西医创伤骨科的研究. E-mail:tr349ex@ 163. com
作者简介:匡嘉兵( 1983—) ,男,硕士研究生,主治医师, 研究方向:主要从事西医创伤骨科的研究. E-mail:cf2018zx@ 163. com
基金资助:
湖北省武汉市卫生健康科研基金 ( WX21Q63 )

Role and Mechanism of miR-494 Targeted TLR-4 Pathway in the Pathogenesis of Osteoporosis

(Department of Orthopedics,Wuhan Fourth Hospital, Wuhan 430060)

Received:2022-03-21 Online:2023-12-28 Published:2024-01-08

摘要/Abstract

摘要： 目的探究 miR-494 在骨质疏松大鼠中的表达及其调控机制。方法选取 30 只 8 周龄雌性 Sprague-Dawley大鼠,构建骨质疏松大鼠模型。双能 X 线吸收仪测定骨密度。 ELISA 检测大鼠血清中骨钙素( BGP) 和总碱性磷酸酶( TALP)含量。分类培养大鼠骨髓间充质干细胞 ( BMSCs) 。 qRT-PCR 检测 miR-494 和 TLR4 mRNA 的表达。Western blot 检测 TLR4 蛋白的表达。双荧光素酶报告基因验证 miR-494 与 TLR-4 的靶向关系。 CCK8 实验检测各组 BMSCs 的增殖能力。茜素红 S 染色检测各组 BMSCs 成骨分化情况。油红 O 染色检测各组 BMSCs 成脂分化情况。结果和 NC 组相比,OP 组大鼠骨密度、BGP 含量、细胞增殖能力、矿化结节数均显著降低,TALP 含量miR494 和 TLR4 的表达、脂肪细胞数均显著升高( P< 0. 05) 。和 OP 组相比,OP +miR-494 inhibitor 组大鼠骨密度、BGP含量、细胞增殖能力、矿化结节数均显著升高,TALP 含量、miR-494 和 TLR4 的表达、脂肪细胞数均显著降低( P <0. 05) 。和 OP+miR-494 inhibitor 组相比,OP+miR-494 inhibitor+TLR-4 vector 组大鼠骨密度、BGP 含量、细胞增殖能力、矿化结节数均显著降低,TALP 含量、miR-494 和 TLR4 的表达、脂肪细胞数均显著升高;OP+miR-494 inhibitor+shTLR-4 组大鼠骨密度、BGP 含量、细胞增殖能力、矿化结节数均显著升高,TALP 含量、miR-494 和 TLR4 的表达、脂肪细胞数均显著降低(P<0. 05) 。结论 miR-494 通过促进 TLR-4 通路的表达,加快大鼠骨质疏松的进展,为骨质疏松的发病机制提供新的理论依据。

关键词: miR-494, TLR-4 通路, 骨质疏松, 发病机制

Abstract: Objective To explore the mechanism of miR-494 on the pathogenesis of osteoporosis in rats by targeting TLR-4 pathway. Method Thirty 8-week-old female Sprague Dawley rats were selected to construct the rat model of osteoporosis. Bone mineral density was measured by dual energy X-ray absorptiometry. The contents of osteocalcin (BGP) and total alkaline phosphatase ( TALP) in rat serum were detected by ELISA. Rat bone marrow mesenchymal stem cells (BMSCs) were cultured. qRT-PCR was used to detect the expression of mir-494 and TLR4 mRNA. The expression of TLR4 protein was detected by Western blot. Double luciferase reporter gene verified the targeting relationship between miR494 and TLR-4. The proliferation ability of BMSCs in each group was detected by CCK8 experiment. Alizarin red S staining was used to detect the osteogenic differentiation of BMSCs in each group. The adipogenic differentiation of BMSCs in each group was detected by oil red O staining. Result Compared with NC group, bone mineral density, BGP content, cell proliferation ability and the number of mineralized nodules in OP group were significantly decreased, while the content of TALP, the expression of miR-494 and TLR4 and the number of adipocytes were significantly increased ( P<0. 05) . Compared with OP group, the bone mineral density, BGP content, cell proliferation ability and the number of mineralized nodules in OP + miR-494 inhibitor group were significantly increased, while the content of TALP, the expression of miR-494 and TLR4 and the number of adipocytes were significantly decreased (P<0. 05) . Compared with OP + miR-494 inhibitor group, the bone mineral density, BGP content, cell proliferation ability and the number of mineralized nodules in OP + miR-494 inhibitor + TLR-4 vector group were significantly decreased, while the content of TALP, the expression of miR-494 and TLR4 and the number of adipocytes were significantly increased; In OP + miR-494 inhibitor + sh TLR-4 group, bone mineral density, BGP content, cell proliferation ability and the number of mineralized nodules increased significantly, while the content of TALP, the expression of mir-494 and TLR4 and the number of adipocytes decreased significantly ( P < 0. 05) . Conclusion MiR-494 can accelerate the progress of osteoporosis in rats by promoting the expression of TLR-4 pathway. To provide a new theoretical basis for the pathogenesis of osteoporosis.

Key words: miR-494, TLR-4 pathway, osteoporosis, pathogenesis

中图分类号:

Q95-3

匡嘉兵, 郭松, 雷建平, 程煜方. miR-494 靶向 TLR-4 通路在骨质疏松发病中的作用及机制[J]. 实验动物科学, 2023, 40(6): 19-25.

KUANG Jiabing, GUO Song, LEI Jianping, CHENG Yufang. Role and Mechanism of miR-494 Targeted TLR-4 Pathway in the Pathogenesis of Osteoporosis[J]. Laboratory Animal Science, 2023, 40(6): 19-25.

0
/ / 推荐

导出引用管理器 EndNote|Ris|BibTeX

链接本文: http://www.sydwkx.com/CN/10. 3969 / j. issn. 1006-6179. 2023. 06. 004

http://www.sydwkx.com/CN/Y2023/V40/I6/19

http://m.chaoxing.com/mqk/read_38502727e7500f266cc1c7ecf61f94a2d46992d394d12e351921b0a3ea255101fc1cf1fbb4666ae697bb3002e6ec17c751bb78a172e67e6ed3675e7d894e906e52f3b539c025c26a5c9acbc5a311fd40?from=screen

[1]	魏朋, 谢高倩, 高玉海, 何玥颖, 秦昆, 陈卓, 柏鑫, 陈克明. 木香烃内酯对生长期大鼠骨强度的影响[J]. 实验动物科学, 2023, 40(5): 60-64.
[2]	阎国强, 刘莉莉, 王超, 赵丹慧. 针刺对青年期去卵巢骨质疏松大鼠骨代谢和骨质量的影响[J]. 实验动物科学, 2023, 40(2): 77-81.
[3]	马艳芳, 张鑫, 李慧, 程东, 孙昌华. 骨质疏松症动物模型中大鼠卵巢切除手术要点及其术后护理[J]. 实验动物科学, 2022, 39(3): 57-62.
[4]	樊萍，冯秀媛，胡楠，蒲丹，吕晓虹，孙怡宁，何岚. 探究绝经后骨质疏松大鼠血清中Dkk-1水平与β-连环蛋白的关系[J]. 实验动物科学, 2020, 37(01): 50-.
[5]	张盼阳，王昭昕，袁晓美，毕亚男，张玥，周昆. 补骨脂酚对去势导致雄性小鼠骨质疏松的治疗[J]. 实验动物科学, 2019, 36(03): 1-.
[6]	苗茸茸，曲显俊. 抑郁症动物模型的研究进展[J]. 实验动物科学, 2019, 36(03): 80-.
[7]	钟志勇，梁志健，刘月姝，李思婷，梁冠泽，谢超敏，唐小江. 糖皮质激素性骨质疏松模型大鼠在性别上的差异性研究[J]. 实验动物科学, 2018, 35(05): 30-.
[8]	刘颖, 袁晓美, 毕亚男, 高玉娜, 周昆, 李云章. 补骨脂对维甲酸诱导的大鼠骨质疏松的治疗[J]. 实验动物科学, 2018, 35(01): 44-.
[9]	周丽;邓伟民;韩丽萍;. 补肾壮骨颗粒对维甲酸致骨质疏松大鼠骨组织计量学的影响[J]. 实验动物科学, 2009, 26(03): 7-10.
[10]	刘庆忠,刘碌,董承超,韩景献. 快速老化模型小鼠SAMP6骨组织形态计量学观察[J]. 实验动物科学, 2004, 21(04): 9-11.
[11]	胡春萍,章熙霞,许立. 多奇胶囊对大鼠实验性骨质疏松症的影响[J]. 实验动物科学, 2003, 20(02): 13-16.
[12]	冷扬,李青南,陈建波,莫梅英,黄连芳,陈文双. 低蛋白和高蛋白饲料对大鼠骨代谢的影响[J]. 实验动物科学, 2002, 19(01): 15-17.
[13]	杨宝华,李忆梅,沈中彦. 骨质疏松症大鼠动物模型的建立和研究[J]. 实验动物科学, 1998, 15(03): 0-0.
[14]	杨新忠,刘发,孙建新. 缺钙大鼠模型的建立[J]. 实验动物科学, 1997, 14(04): 26-27.

miR-494 靶向 TLR-4 通路在骨质疏松发病中的作用及机制

Role and Mechanism of miR-494 Targeted TLR-4 Pathway in the Pathogenesis of Osteoporosis

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 14

编辑推荐

Metrics